Chai Discovery, a start-up focused on using artificial intelligence for drug discovery, has successfully raised $400 million, bringing its valuation to $3.8 billion.

Pfizer has announced a partnership with Chai Discovery to utilize its AI platform in drug development, joining other pharmaceutical giants like Eli Lilly in investing in AI drug discovery startups. This collaboration aims to accelerate the process of bringing new medicines to market.